Back to top

Image: Bigstock

Scotts (SMG) Reports Q3 Earnings: What Key Metrics Have to Say

Read MoreHide Full Article

For the quarter ended June 2026, Scotts Miracle-Gro (SMG - Free Report) reported revenue of $1.17 billion, down 1.3% over the same period last year. EPS came in at $2.82, compared to $2.59 in the year-ago quarter.

The reported revenue represents a surprise of -0.17% over the Zacks Consensus Estimate of $1.17 billion. With the consensus EPS estimate being $2.53, the EPS surprise was +11.46%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Scotts performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Net Sales- Other: $139.2 million compared to the $130.45 million average estimate based on four analysts. The reported number represents a change of +10% year over year.
  • Net Sales- U.S.Consumer reportable segment: $1.03 billion compared to the $1.05 billion average estimate based on four analysts. The reported number represents a change of +0.3% year over year.
  • Segment Profit (Loss) (Non-GAAP)- U.S. Consumer reportable segment: $229.8 million compared to the $166.8 million average estimate based on two analysts.
  • Segment Profit (Loss) (Non-GAAP)- Corporate: $-29.9 million versus $-41.55 million estimated by two analysts on average.
  • Segment Profit (Loss) (Non-GAAP)- Other: $18.6 million compared to the $6.04 million average estimate based on two analysts.

View all Key Company Metrics for Scotts here>>>

Shares of Scotts have returned +7.3% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Published in